APOB and chronic kidney disease: Hypertriglyceridemia, higher levels of low-density lipoprotein cholesterol, lipoprotein(a) particles, and apolipoprotein B (Apo B)-containing lipoproteins, as well as low high-density lipoprotein (HDL) levels, are the most frequent alterations observed in CKD patients.